Osteopontin is associated with increased arterial stiffness in rheumatoid arthritis

Molecular Medicine

Volumn 15, Issue 11-12, 2009, Pages 402-406

  Bazzichi, Laura ^a   Ghiadoni, Lorenzo ^a   Rossi, Alessandra ^a   Bernardini, Melania ^a   Lanza, Mario ^a   De Feo, Francesca ^a   Giacomelli, Camillo ^a   Mencaroni, Ilaria ^a   Raimo, Katia ^a   Rossi, Marco ^a   Mazzone, Anna Maria ^b   Taddei, Stefano ^a   Bombardieri, Stefano ^a  

^a UNIVERSITY OF PISA   (Italy)

^b G PASQUINUCCI HOSPITAL   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN A; C REACTIVE PROTEIN; ENDOTHELIN 1; OSTEOPONTIN;

ADULT; AGE; ARTERIAL STIFFNESS; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RHEUMATOID ARTHRITIS; SYSTEMIC SCLEROSIS;

AGED; AORTA; ARTERIES; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; BLOOD FLOW VELOCITY; BLOOD PRESSURE; CASE-CONTROL STUDIES; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPONTIN; REGRESSION ANALYSIS; STATISTICS, NONPARAMETRIC;

EID: 73249149681     PISSN: 10761551     EISSN: None     Source Type: Journal    
DOI: 10.2119/molmed.2009.00052     Document Type: Article

References (44)

1. Bazzichi L, et al. (2005) Quality of life in rheumatoid arthritis: impact of disability and lifetime depressive spectrum symptomatology. Clin. Exp. Rheumatol. 23:783-8.
2. Riise T, Jacobsen BK, Gran JT, Haga HJ, Arnesen E. (2001) Total mortality is increased in rheumatoid arthritis. A 17-year prospective study. Clin. Rheumatol. 20:123-7.
3. Lévy L, Fautrel B, Barnetche T, Schaeverbeke T. (2008) Incidence and risk of fatal myocardial infarction and stroke events in rheumatoid arthritis patients. A systematic review of the literature. Clin. Exp. Rheumatol. 26:673-679.
4. Gazi IF, Boumpas DT, Mikhailidis DP, Ganotakis ES. (2007) Clustering of cardiovascular risk factors in rheumatoid arthritis: the rationale for using statins. Clin. Exp. Rheumatol. 25:102-111.
5. Mutru O, Laakso M, Isomäki H, Koota K. (1989) Cardiovascular mortality in patients with rheumatoid arthritis. Cardiology. 76:71-7.
6. Wolfe F, et al. (1994) The mortality of rheumatoid arthritis. Arthritis Rheum. 37:481-94.
7. Libby P. (2008) Role of inflammation in atherosclerosis associated with rheumatoid arthritis. Am. J. Med. 121(10 Suppl 1):S21-31.
8. del Rincon ID, Williams K, Stern MP, Freeman GL, Escalante A. (2001) High incidence of cardiovascular events in a rheumatoid arthritis cohort not explained by traditional cardiac risk factors. Arthritis Rheum. 44:2737-45.
9. Goodson N. (2002) Coronary artery disease and rheumatoid arthritis. Curr. Opin. Rheumatol. 14:115-20.
10. Van Doornum S, McColl G, Wicks IP. (2002) Accelerated atherosclerosis: an extraarticular feature of rheumatoid arthritis? Arthritis Rheum. 46:862-73.
11. Lakatta EG. (2003) Arterial and cardiac aging: major shareholders in cardiovascular disease enterprises: Part III: cellular and molecular clues to heart and arterial aging. Circulation. 107:490-7.
12. Laurent S, et al. (2006) Expert consensus document on arterial stiffness: methodological issues and clinical applications. Eur. Heart J. 27:2588-605.
13. Turesson C, et al. (2005) Increased stiffness of the abdominal aorta in women with rheumatoid arthritis. Rheumatology (Oxford). 44:896-901.
14. Roman MJ, et al. (2005) Arterial stiffness in chronic inflammatory diseases. Hypertension. 46:194-9.
15. Maki-Petaja KM, et al. (2006) Rheumatoid arthritis is associated with increased aortic pulse-wave velocity, which is reduced by anti-tumor necrosis factor-alpha therapy. Circulation. 114:1185-92.
16. Cypiene A, et al. (2007) Non-invasive assessment of arterial stiffness indices by applanation tonometry and pulse wave analysis in patients with rheumatoid arthritis treated with TNF-alpha blocker remicade (infliximab). Proc. West Pharmacol. Soc. 50:119-22.
17. Tokita A, et al. (2009) Carotid arterial elasticity is a sensitive atherosclerosis value reflecting visceral fat accumulation in obese subjects. Atherosclerosis. 2009, Feb 20 [Epub ahead of print].
18. Tanaka K, et al. (2006) Paraarticular trabecular bone loss at the ultradistal radius and increased arterial stiffening in postmenopausal patients with rheumatoid arthritis. J Rheumatol. 33:652-8.
19. Scatena M, Liaw L, Giachelli CM. (2007) Osteopontin: a multifunctional molecule regulating chronic inflammation and vascular disease. Arterioscler. Thromb. Vasc. Biol. 27:2302-9.
20. Chen YJ, et al. (2009) Elevated plasma osteopontin level is associated with occurrence of psoriasis and is an unfavorable cardiovascular risk factor in patients with psoriasis. J. Am. Acad. Dermatol. 60:225-30.
21. Altintaş A, Saruhan-Direskeneli G, Benbir G, Demir M, Purisa S. (2009) The role of osteopontin: a shared pathway in the pathogenesis of multiple sclerosis and osteoporosis? J. Neurol. Sci. 276:41-4.
22. Mishima R, et al. (2007) High plasma osteopontin levels in patients with inflammatory bowel disease. J. Clin. Gastroenterol. 41:167-72.
23. Hasegawa M, et al. (2009) Thrombin-cleaved osteopontin in synovial fluid of subjects with rheumatoid arthritis. J. Rheumatol. 36:240-5.
24. Xu AP, et al. (2007) Osteopontin gene polymorphism in association with systemic lupus erythematosus in Chinese patients. Chin. Med. J. (Engl). 120:2124-8.
25. Buommino E, et al. (2009) Osteopontin: a new emerging role in psoriasis. Arch. Dermatol. Res. 301:397-404.
26. Petrow PK, et al. (2002) Characterization of the cell type-specificity of collagenase 3 mRNA expression in comparison with membrane type 1 matrix metalloproteinase and gelatinase A in the synovial membrane in rheumatoid arthritis. Ann. Rheum. Dis. 61:391-7.
27. Ohshima S, et al. (2002) Expression of osteopontin at sites of bone erosion in a murine experimental arthritis model of collagen-induced arthritis: possible involvement of osteopontin in bone destruction in arthritis. Arthritis Rheum. 46:1094-101.
28. Yumoto K, et al. (2002) Osteopontin deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice. Proc. Natl. Acad. Sci. U. S. A. 99:4556-61.
29. Jacobs JP, et al. (2004) Lack of requirement of osteopontin for inflammation, bone erosion, and cartilage damage in the K/BxN model of autoantibody-mediated arthritis. Arthritis Rheum. 50:2685-94.
30. Ohmori R, et al. (2003) Plasma osteopontin levels are associated with the presence and extent of coronary artery disease. Atherosclerosis. 170:333-7.
31. Kato R, et al. (2006) High plasma levels of osteopontin in patients with restenosis after percutaneous coronary intervention. Arterioscler. Thromb. Vasc. Biol. 26:e1-2.
32. Pincus T, Summey JA, Soraci SA Jr, Wallston KA, Hummon NP (1983) Assessment of patient satisfaction in activities of daily living using a modified Stanford Health Assessment Questionnaire. Arthritis Rheum. 26:1346-53.
33. Wolff S. Ferrous ione oxidation in presence of ferric ion indicator xylenol orange for measurement for hydroperoxydes. Methods Enzymol. 1994;233:182-189.
34. Benzie IF, Strain JJ. (1999) Ferric reducing/ antioxidant power assay: direct measure of total antioxidant activity of biological fluids and modified version for simultaneous measurement of total antioxidant power and ascorbic acid concentration. Methods Enzymol. 299:15-27
35. Plantinga Y, et al. (2007) Supplementation with vitamins C and E improves arterial stiffness and endothelial function in essential hypertensive patients. Am. J. Hypertens. 20:392-7.
36. Kapoor S. (2008) Osteopontin: a major player in the pathogenesis of endocrine and systemic diseases. Endocr. J. 55:785.
37. Mirza M, et al. (2008) Osteopontin-c is a selective marker of breast cancer. Int. J. Cancer. 122:889-97.
38. Chiocchetti A, et al. (2005) Osteopontin gene haplotypes correlate with multiple sclerosis development and progression. J. Neuroimmunol. 163:172-8.
39. Wong CK, Lit LC, Tam LS, Li EK, Lam CW. (2005) Elevation of plasma osteopontin concentration is correlated with disease activity in patients with systemic lupus erythematosus. Rheumatology (Oxford). 44:602-6.
40. Xu G, et al. (2005) Role of osteopontin in amplification and perpetuation of rheumatoid synovitis. J. Clin. Invest. 115:1060-7.
41. Takemoto M, et al. (1999) Effects of aging and hyperlipidemia on plasma osteopontin level. Nippon Ronen Igakkai Zasshi. 36:799-802.
42. Du J, et al. (2008) Molecular basis of recognition of human osteopontin by 23C3, a potential therapeutic antibody for treatment of rheumatoid arthritis. J. Mol. Biol. 382:835-42.
43. de las Fuentes L, et al. (2008) Osteopontin promoter polymorphism is associated with increased carotid intima-media thickness. J. Am. Soc. Echocardiogr. 21:954-60.
44. Brenner D, et al. (2006) Cytokine polymorphisms associated with carotid intima-media thickness in stroke patients. Stroke. 37:1691-6.